"The Henry Ford Cancer Institute - Detroit has been designed to deliver an exceptional care experience surrounded in compassion, convenience, innovation, and most importantly, HOPE. Our new cancer pavilion is a global destination site for ambulatory cancer treatment, precision medicine, clinical trials and research, and enhanced cancer support services. Here you'll find one strong, integrated team, ensuring you have access to the latest advances in cancer treatment, research, clinical trials and support for a truly seamless experience at each step of your cancer journey."

During the past decade, Henry Ford Hospital - Hematology/oncology conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Henry Ford Hospital - Hematology/oncology" are "Multiple Myeloma" (2 trials), "Breast Cancer" (1 trials), "Non-Squamous Non-Small Cell Lung Cancer" (1 trials) and "Respiratory Syncytial Virus Infections" (1 trials). Many other conditions were trialed in "Henry Ford Hospital - Hematology/oncology" in a lesser frequency.

Most popular intervention types in "Henry Ford Hospital - Hematology/oncology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Docetaxel" (2 trials), "Lenalidomide" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Henry Ford Hospital - Hematology/oncology" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Henry Ford Hospital - Hematology/oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Henry Ford Hospital - Hematology/oncology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Henry Ford Hospital - Hematology/oncology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".